AIDS as a zoonosis: Scientific and public health implications

Science

Volumn 287, Issue 5453, 2000, Pages 607-614

  Hahn, Beatrice H ^a   Shaw, George M ^a   De Cock, Kevin M ^b   Sharp, Paul M ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; EPIDEMIC; EVOLUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; LENTIVIRINAE; NONHUMAN; PHYLOGENY; PRIMATE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS RECOMBINATION; VIRUS TRANSMISSION; ZOONOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA, WESTERN; AMINO ACID SEQUENCE; ANIMALS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; HAPLORHINI; HIV-1; HIV-2; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PUBLIC HEALTH; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; ZOONOSES;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; PAN (APE); PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0034723385     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.287.5453.607     Document Type: Review

References (99)

1. J. Lederberg, R. E. Shope, S. C. Oaks, Emerging Infections; Microbial Threats to Health in the United States (National Academy Press, Washington, DC, 1992); Centers for Disease Control and Prevention, Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States (U.S. Department of Health and Human Services, Atlanta, GA 1994); Preventing Emerging Infectious Diseases: A Strategy for the 21st Century (U.S. Department of Health and Human Services, Atlanta, GA 1998), www.cdc.gov/ncidod/emergplan.
2. J. Lederberg, R. E. Shope, S. C. Oaks, Emerging Infections; Microbial Threats to Health in the United States (National Academy Press, Washington, DC, 1992); Centers for Disease Control and Prevention, Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States (U.S. Department of Health and Human Services, Atlanta, GA 1994); Preventing Emerging Infectious Diseases: A Strategy for the 21st Century (U.S. Department of Health and Human Services, Atlanta, GA 1998), www.cdc.gov/ncidod/emergplan.
3. J. Lederberg, R. E. Shope, S. C. Oaks, Emerging Infections; Microbial Threats to Health in the United States (National Academy Press, Washington, DC, 1992); Centers for Disease Control and Prevention, Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States (U.S. Department of Health and Human Services, Atlanta, GA 1994); Preventing Emerging Infectious Diseases: A Strategy for the 21st Century (U.S. Department of Health and Human Services, Atlanta, GA 1998), www.cdc.gov/ncidod/emergplan.
4. AIDS Epidemic Update: December 1999 (UNAIDS, Geneva, 1999), www.unaids.org.
5. Human Retroviruses and AIDS 1998: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Los Alamos National Laboratory, Los Alamos, NM, 1998), http://hiv-web.lanl.gov.
6. F. Gao et al., Nature 397, 436 (1999).
7. F. Gao et al., Nature 358, 495 (1992); F. Gao et al., J. Virol. 68, 7433 (1994); Z. Chen et al., J. Virol. 71, 3953 (1997).
8. F. Gao et al., Nature 358, 495 (1992); F. Gao et al., J. Virol. 68, 7433 (1994); Z. Chen et al., J. Virol. 71, 3953 (1997).
9. F. Gao et al., Nature 358, 495 (1992); F. Gao et al., J. Virol. 68, 7433 (1994); Z. Chen et al., J. Virol. 71, 3953 (1997).
10. Z. Chen et al., J. Virol. 70, 3617 (1996).
11. P. M. Sharp et al., Biochem. Soc. Trans. 28, 275 (2000).
12. J. S. Allan et al., J. Virol. 65, 2816 (1991); M. C. Muller et al., J. Virol. 67, 1227 (1993).
13. J. S. Allan et al., J. Virol. 65, 2816 (1991); M. C. Muller et al., J. Virol. 67, 1227 (1993).
14. M. J. Jin et al., EMBO J. 13, 2935 (1994).
15. P. A. Morin et al., Science 265, 1193 (1994); M. K. Gonder et al., Nature 388, 337 (1997).
16. P. A. Morin et al., Science 265, 1193 (1994); M. K. Gonder et al., Nature 388, 337 (1997).
17. S. Corbet et al., J. Virol. 74, 529 (2000).
18. M. M. Vanden Haesevelde et al., Virology 221, 346 (1996).
19. B. Dutrillaux, M. Muleris, J. Couturier, in A Primate Radiation: Evolutionary Biology of the African Guenons, A, Gautier-Hion, F. Bourliere, J.-P. Gautier, J. Kingdon, Eds. (Cambridge Univ. Press, Cambridge, 1988), pp. 150-159; J.-P. Gautier, ibid., pp. 194-226; R. D. Martin and A. M. MacLarnon, ibid., pp. 160-183.
20. B. Dutrillaux, M. Muleris, J. Couturier, in A Primate Radiation: Evolutionary Biology of the African Guenons, A, Gautier-Hion, F. Bourliere, J.-P. Gautier, J. Kingdon, Eds. (Cambridge Univ. Press, Cambridge, 1988), pp. 150-159; J.-P. Gautier, ibid., pp. 194-226; R. D. Martin and A. M. MacLarnon, ibid., pp. 160-183.
21. B. Dutrillaux, M. Muleris, J. Couturier, in A Primate Radiation: Evolutionary Biology of the African Guenons, A, Gautier-Hion, F. Bourliere, J.-P. Gautier, J. Kingdon, Eds. (Cambridge Univ. Press, Cambridge, 1988), pp. 150-159; J.-P. Gautier, ibid., pp. 194-226; R. D. Martin and A. M. MacLarnon, ibid., pp. 160-183.
22. F. Bibollet-Ruche et al., abstract to be presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January 2000 (http:// www.retroconference.org/abstracts).
23. V. M. Hirsch, R. A. Olmsted, M. Murphey-Corb, R. H. Purcell, P. R. Johnson, Nature 339, 389 (1989).
24. N. L. Letvin et al., Science 230, 71 (1985); M. D. Daniel et al., Science 228, 1201 (1985); M. Murphey-Corb et al., Nature 321, 435 (1986); L. Chakrabarti et al., Nature 328, 543 (1987); M. D. Daniel et al., J. Gen. Virol. 68, 3183 (1987).
25. N. L. Letvin et al., Science 230, 71 (1985); M. D. Daniel et al., Science 228, 1201 (1985); M. Murphey-Corb et al., Nature 321, 435 (1986); L. Chakrabarti et al., Nature 328, 543 (1987); M. D. Daniel et al., J. Gen. Virol. 68, 3183 (1987).
26. N. L. Letvin et al., Science 230, 71 (1985); M. D. Daniel et al., Science 228, 1201 (1985); M. Murphey-Corb et al., Nature 321, 435 (1986); L. Chakrabarti et al., Nature 328, 543 (1987); M. D. Daniel et al., J. Gen. Virol. 68, 3183 (1987).
27. N. L. Letvin et al., Science 230, 71 (1985); M. D. Daniel et al., Science 228, 1201 (1985); M. Murphey-Corb et al., Nature 321, 435 (1986); L. Chakrabarti et al., Nature 328, 543 (1987); M. D. Daniel et al., J. Gen. Virol. 68, 3183 (1987).
28. N. L. Letvin et al., Science 230, 71 (1985); M. D. Daniel et al., Science 228, 1201 (1985); M. Murphey-Corb et al., Nature 321, 435 (1986); L. Chakrabarti et al., Nature 328, 543 (1987); M. D. Daniel et al., J. Gen. Virol. 68, 3183 (1987).
29. F. Bibollet-Ruche et al., J. Gen. Virol. 77, 773 (1996).
30. M. J. Jin et al., J. Virol. 68, 8454 (1994).
31. E. J. van Rensburg et al., J. Gen. Virol. 79, 1809 (1998).
32. M. C. Georges-Courbot et al., J. Virol. 72, 600 (1998).
33. F. Gao et al., unpublished data.
34. F. Simon et al., abstract presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 31 January 1999 (http://www.retroconference. org/99/posters/session14.htm); F. Simon, unpublished data.
35. F. Simon et al., abstract presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, 31 January 1999 (http://www.retroconference. org/99/posters/session14.htm); F. Simon, unpublished data.
36. H. Tsujimoto et al., Nature 341, 539 (1989); E. Nerrienet et al., AIDS Res. Hum. Retroviruses 14, 785 (1998).
37. H. Tsujimoto et al., Nature 341, 539 (1989); E. Nerrienet et al., AIDS Res. Hum. Retroviruses 14, 785 (1998).
38. B. E. Beer et al., J. Virol. 73, 7734 (1999).
39. K. M. De Cock et al., JAMA 270, 2083 (1993).
40. M. F. Schim van der Loeff and P. Aaby, AIDS 13, S69 (1999).
41. T. Huet, R. Cheynier, A. Meyerhans, G. Roelants, S. Wain-Hobson, Nature 345, 356 (1990).
42. M. Peeters et al., AIDS 3, 625 (1989); M. Peeters et al., AIDS 6, 447 (1992); W. Janssens et al., AIDS Res. Hum. Retroviruses 10, 1191 (1994).
43. M. Peeters et al., AIDS 3, 625 (1989); M. Peeters et al., AIDS 6, 447 (1992); W. Janssens et al., AIDS Res. Hum. Retroviruses 10, 1191 (1994).
44. M. Peeters et al., AIDS 3, 625 (1989); M. Peeters et al., AIDS 6, 447 (1992); W. Janssens et al., AIDS Res. Hum. Retroviruses 10, 1191 (1994).
45. D. B. Hrdy, Rev. Infect. Dis. 9, 1109 (1987); J. Sonnet et al., Scand. J. Infect. Dis. 19, 511 (1987).
46. D. B. Hrdy, Rev. Infect. Dis. 9, 1109 (1987); J. Sonnet et al., Scand. J. Infect. Dis. 19, 511 (1987).
47. F. Simon et al., Nature Med. 4, 1032 (1998); S. Souquière et al., abstract to be presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January 2000 (http://www. retroconference.org/abstracts).
48. F. Simon et al., Nature Med. 4, 1032 (1998); S. Souquière et al., abstract to be presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January 2000 (http://www. retroconference.org/abstracts).
49. L. G. Gürtler et al., Arch. Virol. Suppl. 11, 195 (1996); M. Peeters et al., AIDS 11, 493 (1997); P. Mauclere et al., AIDS 11, 445 (1997).
50. L. G. Gürtler et al., Arch. Virol. Suppl. 11, 195 (1996); M. Peeters et al., AIDS 11, 493 (1997); P. Mauclere et al., AIDS 11, 445 (1997).
51. L. G. Gürtler et al., Arch. Virol. Suppl. 11, 195 (1996); M. Peeters et al., AIDS 11, 493 (1997); P. Mauclere et al., AIDS 11, 445 (1997).
52. J. N. Nkengasong et al., AIDS 8, 1405 (1994); E. Delaporte et al., AIDS 10, 903 (1996); J. Takehisa et al., Virology 245, 1 (1998).
53. J. N. Nkengasong et al., AIDS 8, 1405 (1994); E. Delaporte et al., AIDS 10, 903 (1996); J. Takehisa et al., Virology 245, 1 (1998).
54. J. N. Nkengasong et al., AIDS 8, 1405 (1994); E. Delaporte et al., AIDS 10, 903 (1996); J. Takehisa et al., Virology 245, 1 (1998).
55. T. Zhu et al., Nature 391, 594 (1998).
56. T. O. Jonassen et al., Virology 231, 43 (1997).
57. W.-H. Li, M. Tanimura, P. M. Sharp, Mol. Biol. Evol. 5, 313 (1988); C. L. Kuiken and B. T. M. Korber, AIDS 8, S73 (1994).
58. W.-H. Li, M. Tanimura, P. M. Sharp, Mol. Biol. Evol. 5, 313 (1988); C. L. Kuiken and B. T. M. Korber, AIDS 8, S73 (1994).
59. B. Korber, J. Theiler, S. Wolinsky, Science 280, 1868 (1998).
60. B. Korber et al., in preparation.
61. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 41, 678 (1992); Morb. Mortal. Wkly. Rep. 41, 814 (1992); R. F. Khabbaz et al., N. Engl. J. Med. 330, 172 (1994); Centers for Disease Control and Prevention, Surveillance of Health Care Workers with HIV/AIDS (U.S. Department of Health and Human Services, Atlanta, GA 1999), www.cdc. gov/nchstp/hiv-aids/pubs/facts/hcwsurv.htm.
62. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 41, 678 (1992); Morb. Mortal. Wkly. Rep. 41, 814 (1992); R. F. Khabbaz et al., N. Engl. J. Med. 330, 172 (1994); Centers for Disease Control and Prevention, Surveillance of Health Care Workers with HIV/AIDS (U.S. Department of Health and Human Services, Atlanta, GA 1999), www.cdc. gov/nchstp/hiv-aids/pubs/facts/hcwsurv.htm.
63. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 41, 678 (1992); Morb. Mortal. Wkly. Rep. 41, 814 (1992); R. F. Khabbaz et al., N. Engl. J. Med. 330, 172 (1994); Centers for Disease Control and Prevention, Surveillance of Health Care Workers with HIV/AIDS (U.S. Department of Health and Human Services, Atlanta, GA 1999), www.cdc. gov/nchstp/hiv-aids/pubs/facts/hcwsurv.htm.
64. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 41, 678 (1992); Morb. Mortal. Wkly. Rep. 41, 814 (1992); R. F. Khabbaz et al., N. Engl. J. Med. 330, 172 (1994); Centers for Disease Control and Prevention, Surveillance of Health Care Workers with HIV/AIDS (U.S. Department of Health and Human Services, Atlanta, GA 1999), www.cdc. gov/nchstp/hiv-aids/pubs/facts/hcwsurv.htm.
65. P. Gould, The Slow Plague: A Geography of the AIDS Pandemic (Blackwell, Cambridge, MA, 1993); J. Verdrager, Bull. Soc. Pathol. Exot. 88, 54 (1995); A. Chitnis, D, Rawls, J. Moore, AIDS Res. Hum. Retroviruses 16, 5 (2000).
66. P. Gould, The Slow Plague: A Geography of the AIDS Pandemic (Blackwell, Cambridge, MA, 1993); J. Verdrager, Bull. Soc. Pathol. Exot. 88, 54 (1995); A. Chitnis, D, Rawls, J. Moore, AIDS Res. Hum. Retroviruses 16, 5 (2000).
67. P. Gould, The Slow Plague: A Geography of the AIDS Pandemic (Blackwell, Cambridge, MA, 1993); J. Verdrager, Bull. Soc. Pathol. Exot. 88, 54 (1995); A. Chitnis, D, Rawls, J. Moore, AIDS Res. Hum. Retroviruses 16, 5 (2000).
68. A. Buve, M. Carael, R. Hayes, N. J. Robinson, AIDS 9 (suppl. A), S103 (1995); K. M. De Cock, Rev. Epidem. Sante Publ. 44, 511 (1996).
69. A. Buve, M. Carael, R. Hayes, N. J. Robinson, AIDS 9 (suppl. A), S103 (1995); K. M. De Cock, Rev. Epidem. Sante Publ. 44, 511 (1996).
70. M. R. May and R. M. Anderson, Nature 326, 137 (1987).
71. T. Curtis, Rolling Stone (no. 626), 54 (1992); B. F. Elswood and R. B. Stricker, Med. Hypotheses 48, 193 (1997); E. Hooper, The River: A Journey to the Source of HIV and AIDS (Little, Brown, New York, 1999).
72. T. Curtis, Rolling Stone (no. 626), 54 (1992); B. F. Elswood and R. B. Stricker, Med. Hypotheses 48, 193 (1997); E. Hooper, The River: A Journey to the Source of HIV and AIDS (Little, Brown, New York, 1999).
73. T. Curtis, Rolling Stone (no. 626), 54 (1992); B. F. Elswood and R. B. Stricker, Med. Hypotheses 48, 193 (1997); E. Hooper, The River: A Journey to the Source of HIV and AIDS (Little, Brown, New York, 1999).
74. S. Delassus, R. Cheynier, S, Wain-Hobson J. Virol. 65, 225 (1991); R. S. Diaz et al., J. Virol. 69, 3273 (1995); J. Vartanian, A. Meyerhans, B. Asjo, S. Wain-Hobson, J. Virol. 65, 1779 (1991).
75. S. Delassus, R. Cheynier, S, Wain-Hobson J. Virol. 65, 225 (1991); R. S. Diaz et al., J. Virol. 69, 3273 (1995); J. Vartanian, A. Meyerhans, B. Asjo, S. Wain-Hobson, J. Virol. 65, 1779 (1991).
76. S. Delassus, R. Cheynier, S, Wain-Hobson J. Virol. 65, 225 (1991); R. S. Diaz et al., J. Virol. 69, 3273 (1995); J. Vartanian, A. Meyerhans, B. Asjo, S. Wain-Hobson, J. Virol. 65, 1779 (1991).
77. E. C. Holmes et al., in New Uses for New Phylogenies, P. H. Harvey, A. J. Leigh Brown, J. Maynard Smith, S. Nee, Eds. (Oxford Univ. Press, Oxford, 1996), pp. 169-186.
78. P. M. Sharp, D. L. Robertson, F. Gao, AIDS 8 (suppl. 1), S27 (1994).
79. M. Santiago et al., abstract to be presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January 2000 (http://www. retroconference.org/abstracts).
80. G. Djomand et al., AIDS 8, 843 (1994).
81. J. G. Robinson, K. H. Redford, E. L. Bennet, Science 284, 595 (1999).
82. V. M. Hirsch et al., J. Virol. 73, 1036 (1999); B. E. Beer et al., J. Virol., in press.
83. V. M. Hirsch et al., J. Virol. 73, 1036 (1999); B. E. Beer et al., J. Virol., in press.
84. P. M. Sharp, D. L. Robertson, B. H. Hahn, Philos. Trans. R. Soc. London Ser. B 349, 41 (1995).
85. J. Takehisa et al., J. Virol. 73, 6810 (1999).
86. Most likely topologies were first derived using the JTT model [D. T. Jones, W. R. Taylor, J. M. Thornton, CABIOS 8, 275 (1992)], with input amino acid frequencies and shuffled sequence input order implemented in PROTML (J. Adachi and M. Hasegawa, MOLPHY version 2.2, Institute of Statistical Mathematics, Tokyo, 1994). Approximately 40 best topologies were subjected to further likelihood analysis, estimating an alpha parameter for gamma-distributed rate variation among sites, implemented in CODEML [Z. Yang, CABIOS 12, 555 (1997)]. The maximum-likelihood tree found (alpha estimated as 0.74 for Pol, 0.76 for Env) is shown, midpoint-rooted.
87. Most likely topologies were first derived using the JTT model [D. T. Jones, W. R. Taylor, J. M. Thornton, CABIOS 8, 275 (1992)], with input amino acid frequencies and shuffled sequence input order implemented in PROTML (J. Adachi and M. Hasegawa, MOLPHY version 2.2, Institute of Statistical Mathematics, Tokyo, 1994). Approximately 40 best topologies were subjected to further likelihood analysis, estimating an alpha parameter for gamma-distributed rate variation among sites, implemented in CODEML [Z. Yang, CABIOS 12, 555 (1997)]. The maximum-likelihood tree found (alpha estimated as 0.74 for Pol, 0.76 for Env) is shown, midpoint-rooted.
88. Most likely topologies were first derived using the JTT model [D. T. Jones, W. R. Taylor, J. M. Thornton, CABIOS 8, 275 (1992)], with input amino acid frequencies and shuffled sequence input order implemented in PROTML (J. Adachi and M. Hasegawa, MOLPHY version 2.2, Institute of Statistical Mathematics, Tokyo, 1994). Approximately 40 best topologies were subjected to further likelihood analysis, estimating an alpha parameter for gamma-distributed rate variation among sites, implemented in CODEML [Z. Yang, CABIOS 12, 555 (1997)]. The maximum-likelihood tree found (alpha estimated as 0.74 for Pol, 0.76 for Env) is shown, midpoint-rooted.
89. V. M. Hirsch et al., J. Virol. 67, 1517 (1993).
90. I. Nicol et al., J. Med. Primatol. 18, 227 (1989).
91. M. Fukasawa et al., Nature 333, 457 (1988).
92. A. Fomsgaard, V. M. Hirsch, J. S. Allan, P. R. Johnson, Virology 182, 397 (1991).
93. V. M. Hirsch et al., Virology 197, 426 (1993); M. A. Soares et al., Virology 228, 394 (1997).
94. V. M. Hirsch et al., Virology 197, 426 (1993); M. A. Soares et al., Virology 228, 394 (1997).
95. A. D. M. E. Osterhaus et al., Virology 260, 116 (1999).
96. V. Courgnaud et al., abstract to be presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January 2000 (http:// www.retroconference.org/abstracts).
97. J. P. Clewley, J. C. M. Lewis, D. W. C. Brown, E. L. Gadsby, J. Virol. 72, 10305 (1998).
98. L. Lowenstein et al., Int. J. Cancer 38, 563 (1986).
99. We thank E. Bailes for phylogenetic tree constructions, F. Barre-Sinoussi and M. Muller-Trutwin for unpublished SIVcpz sequences, K. Ammann for photographs of the bushmeat trade, and J. B. Wilson and W. J. Abbott for artwork and manuscript preparation. Supported by NIH grants NO1 Al 85338, RO1 Al 44596, and RO1 Al 40951 (B.H.H.) and by the Howard Hughes Medical Institute (G.M.S.).